The MEDICREA Group reported sales results for the first quarter ended March 31, 2014. For the quarter, the company reported sales were EUR 5,376,000 against EUR 5,405,000 a year ago. The Group has continued its development in the United States with sales up 18% in dollars in the first quarter of 2014 compared with the same period of 2013. In France, over the quarter the Group recorded sales growth of close to 40% due to the extension of its product range and its referencing in new hospitals.

The strengthening of the sales teams in the United States and France, as well as the recent recruitments aimed at strengthening the international sales team, will see their full effects over the second half of 2014. Moreover, the Group is about to launch a major product innovation that should allow it to move up to the next level and accelerate its sales growth, primarily in the United States.